11.1 Information on toxicological effects
Acute toxicity
Oral: No data available
LD50 Oral - 5.1 mg/kg
LC50 Inhalation - 4 h - 0.005 mg/l - dust/mist
LD50 Dermal - 51 mg/kg
Skin corrosion/irritation
Remarks: No data available
Serious eye damage/eye irritation
Remarks: No data available
Respiratory or skin sensitization
Classified based on available data. For more details, see section 2
Germ cell mutagenicity
Classified based on available data. For more details, see section 2
Carcinogenicity
Classified based on available data. For more details, see section 2
Reproductive toxicity
Classified based on available data. For more details, see section 2
Specific target organ toxicity - single exposure
Classified based on available data. For more details, see section 2
Specific target organ toxicity - repeated exposure
Classified based on available data. For more details, see section 2
Aspiration hazard
Classified based on available data. For more details, see section 2
11.2 Additional Information
Cholinesterese inhibitor
Cholinesterase inhibitors can cause heavy salivation and secretion in the lungs, lachrymation, blurred vision, involuntary defecation, diarrhea, tremor, ataxia, sweating, hypothermia, lowered heart rate, and/or a fall in blood pressure as a result of their action at cholinergic nerve sites., Headache, Nausea, Vomiting, Dizziness, Drowsiness, Confusion.,
Weakness, Muscle cramps/spasms., Change in pupil size., Fever, Seizures., Incoordination.